BioXcel Therapeutics, Inc. (BTAIQ)
0.052
+0.01
(+15.56%)
USD |
OTCM |
Oct 02, 16:00
BioXcel Therapeutics Net Income (Quarterly) : -14.71M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.71M |
| March 31, 2026 | -12.69M |
| December 31, 2025 | -12.54M |
| September 30, 2025 | -30.91M |
| June 30, 2025 | -19.19M |
| March 31, 2025 | -7.254M |
| December 31, 2024 | -10.86M |
| September 30, 2024 | -13.65M |
| June 30, 2024 | -8.299M |
| March 31, 2024 | -26.79M |
| December 31, 2023 | -22.26M |
| September 30, 2023 | -50.49M |
| June 30, 2023 | -53.52M |
| March 31, 2023 | -52.80M |
| December 31, 2022 | -54.81M |
| September 30, 2022 | -41.80M |
| June 30, 2022 | -37.67M |
| March 31, 2022 | -31.47M |
| December 31, 2021 | -26.12M |
| Date | Value |
|---|---|
| September 30, 2021 | -26.81M |
| June 30, 2021 | -27.62M |
| March 31, 2021 | -26.38M |
| December 31, 2020 | -21.09M |
| September 30, 2020 | -24.75M |
| June 30, 2020 | -21.42M |
| March 31, 2020 | -14.91M |
| December 31, 2019 | -8.275M |
| September 30, 2019 | -9.018M |
| June 30, 2019 | -8.471M |
| March 31, 2019 | -7.204M |
| December 31, 2018 | -7.075M |
| September 30, 2018 | -4.887M |
| June 30, 2018 | -3.026M |
| March 31, 2018 | -4.282M |
| December 31, 2017 | -2.528M |
| September 30, 2017 | -0.917M |
| December 31, 2016 | -0.561M |
| September 30, 2016 | -0.542M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
| Curis, Inc. | -8.581M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.182M |
| Total Expenses (Quarterly) | 14.90M |
| EPS Diluted (Quarterly) | -0.4856 |
| Enterprise Value | 92.28M |
| Gross Profit Margin (Quarterly) | 78.02% |
| Profit Margin (Quarterly) | -8.08K% |
| Earnings Yield | -8.13K% |
| Normalized Earnings Yield | -7054.04 |